Literature DB >> 19090728

The assembly and activation of kinin-forming systems on the surface of human U-937 macrophage-like cells.

Anna Barbasz1, Andrzej Kozik.   

Abstract

A complex of three plasma proteins, including the high molecular mass kininogen (HK), prekallikrein (PK), and factor XII (FXII), is known to assemble on cell surfaces to release bradykinin-related proinflammatory peptides (kinins). Only recently, the binding of HK to human macrophages was described in the U-937 cell line model. In the present study, the adsorption of the other components of plasma kinin-generating system to these cells was characterized. FXII was found to tightly bind to U-937 cells and was also shown to partially compete with HK for the same binding sites on the macrophage surface. The Mac-1 and gClqR proteins were found to be receptors for FXII on the cell surface. PK indirectly docked to the macrophages via the cell-bound HK and FXII. Within the complex of these proteins assembled on the macrophage, PK could be activated by FXII/FXIIa or independently of this factor, and the active PK effectively released kinins from HK. The cell surface-bound HK could also be the substrate for tissue kallikrein approaching the cell from the bulk fluid. The kinins released at the surface are suggested to induce secondary responses in the macrophages, leading to further propagation of the inflammatory state.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19090728     DOI: 10.1515/BC.2009.032

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  8 in total

1.  Adsorption of components of the plasma kinin-forming system on the surface of Porphyromonas gingivalis involves gingipains as the major docking platforms.

Authors:  Maria Rapala-Kozik; Grazyna Bras; Barbara Chruscicka; Justyna Karkowska-Kuleta; Aneta Sroka; Heiko Herwald; Ky-Anh Nguyen; Sigrun Eick; Jan Potempa; Andrzej Kozik
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

Review 2.  Fungal proteases and their pathophysiological effects.

Authors:  Iwona Yike
Journal:  Mycopathologia       Date:  2011-01-23       Impact factor: 2.574

3.  Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells.

Authors:  J S Coelho dos Santos; C A S Menezes; F N A Villani; L M D Magalhães; J Scharfstein; K J Gollob; W O Dutra
Journal:  Clin Exp Immunol       Date:  2010-10-21       Impact factor: 4.330

4.  Establishment and Application of a Prognostic Risk Score Model Based on Characteristics of Different Immunophenotypes for Lung Adenocarcinoma.

Authors:  Hong Gao; Yanhong Liu; Yue Hu; Meiling Ge; Jie Ding; Qing Ye
Journal:  Front Genet       Date:  2022-04-25       Impact factor: 4.772

5.  Kinin release from human kininogen by 10 aspartic proteases produced by pathogenic yeast Candida albicans.

Authors:  Andrzej Kozik; Mariusz Gogol; Oliwia Bochenska; Justyna Karkowska-Kuleta; Natalia Wolak; Wojciech Kamysz; Wataru Aoki; Mitsuyoshi Ueda; Alexander Faussner; Maria Rapala-Kozik
Journal:  BMC Microbiol       Date:  2015-03-04       Impact factor: 3.605

6.  Ecotin-like ISP of L. major promastigotes fine-tunes macrophage phagocytosis by limiting the pericellular release of bradykinin from surface-bound kininogens: a survival strategy based on the silencing of proinflammatory G-protein coupled kinin B2 and B1 receptors.

Authors:  Erik Svensjö; Larissa Nogueira de Almeida; Lucas Vellasco; Luiz Juliano; Julio Scharfstein
Journal:  Mediators Inflamm       Date:  2014-09-10       Impact factor: 4.711

7.  Cryptococcal Protease(s) and the Activation of SARS-CoV-2 Spike (S) Protein.

Authors:  Nozethu Mjokane; Maphori Maliehe; Olufemi S Folorunso; Adepemi O Ogundeji; Onele M N Gcilitshana; Jacobus Albertyn; Carolina H Pohl; Olihile M Sebolai
Journal:  Cells       Date:  2022-01-27       Impact factor: 6.600

Review 8.  Roles of Factor XII in Innate Immunity.

Authors:  Thomas Renné; Evi X Stavrou
Journal:  Front Immunol       Date:  2019-08-22       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.